Kannika Numuang
About Kannika Numuang
Kannika Numuang is the Director of Market Access and Public Policy at BeiGene in Bangkok, Thailand, with extensive experience in patient and market access roles across multiple pharmaceutical companies.
Title
Kannika Numuang is the Director of Market Access and Public Policy at BeiGene in Bangkok City, Thailand.
Company
Kannika Numuang is currently working at BeiGene, a global biotechnology company focused on developing and commercializing innovative cancer therapies.
Professional Experience
Kannika has an extensive career in the pharmaceutical industry, having held various positions in patient access, market access, and clinical research. She worked at Novartis in multiple roles, including Head of Patient Access, Pharmaceuticals, and Country Head of Value and Access, over a period of 9 years. Prior to her tenure at Novartis, she served as Market Access and Outcomes Research Manager at MSD and as Health Economics Associate at Roche. She also has experience as a Senior Clinical Research Associate at Quintiles (Thailand) Co., Ltd. and in multiple roles at Harn Thai Pharma Limited, Partnership.
Education and Expertise
Kannika Numuang holds a Master of Science in Health Economics from the Faculty of Economics, Chulalongkorn University. She also earned a Bachelor of Science in Pharmacy from Mahidol University. Her educational background combines pharmacy and health economics, equipping her with both clinical and economic expertise.
Background
Kannika's professional journey began at Harn Thai Pharma Limited, Partnership, where she served in various capacities, including Quality Assurance, Clinical Research Associate, and Head of the Scientific Support Department. Her diverse roles have provided her with a broad skill set encompassing quality assurance, clinical research, and business development in the pharmaceutical sector.